Expression of Bcl-2 and Bax in cultured normal human keratinocytes and melanocytes: Relationship to differentiation and melanogenesis

British Journal of Dermatology

Volumn 137, Issue 6, 1997, Pages 883-889

  Sermadiras, S ^a,c   Dumas, M ^a   Joly Berville, R ^a   Bonte F ^a   Meybeck, A ^b   Ratinaud, M H ^c  

^a Christian Dior   (France)

^b Parfums Christian Dior   (France)

^c UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MELANOCYTE; MELANOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTO ONCOGENE;

EID: 0031450324     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01547.x     Document Type: Article

References (31)

1. Cohen JJ. Apoptosis. Immunol Today 1995; 14: 126-30.
2. Budtz PE, Spies I. Epidermal tissue homeostasis: apoptosis and cell emigration as a mechanism of controlled cell death in the epidermis of the toad Bufo bufo. Cell Tissue Res 1989; 256: 475-86.
3. McCall CA, Cohen JJ. Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonucleases. J Invest Dermatol 1991; 97: 111-14.
4. Polakowska RR, Piacentini M, Bartlett R et al. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dynamics 1994; 199: 176-88.
5. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
6. Haake AR, Polakowska RR. UV-induced apoptosis in skin equivalents: inhibition by phorbol esters and Bcl-2 overexpression. Cell Death Diff 1995; 2: 183-93.
7. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996; 93: 2239-44.
8. Norris DA. Differential control of cell death in the skin. Arch Dermatol 1995; 131: 945-8.
9. Korsmeyer SJ, Shuttler JR, Veis DJ et al. Bcl2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993; 4: 327-32.
10. Larsen CJ. The Bcl2 gene is the prototype of a gene family that controls programmed cell death (apoptosis). Ann Genet 1994; 37: 121-34.
11. Hockenbery DM, Zutter M, Hickey W et al. Bcl2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-5.
12. Rodriguez-Villanueva J, Colome MI, Brisbay S, McDonnel TJ. The expression and localisation of Bcl-2 protein in normal skin and in non-melanoma skin cancers. Pathol Res Pract 1995; 191: 391-8.
13. Plettenberg A, Ballaun C, Strunk D et al. Expression of the Bcl-2 proto-oncogene in normal human epidermis. J Invest Dermatol 1994; 102: 645 (Abstr.).
14. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domain of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369: 321-3.
15. Maftah A, Ratinaud MH, Dumas M et al. Human epidermal cells progressively lose their cardiolipins during ageing without change in mitochondrial transmembrane potential. Mech Ageing Dev 1994; 77: 83-96.
16. Dyer MJS, Fisher P, Nacheva E et al. A new human B cell non-Hodgkins lymphoma cell line (Karpas 422) exhibiting both T (14-18) and T (4-11) chromosomal translocation. Blood 1990; 3: 709-14.
17. Detmar M, Dumas M, Bonté F et al. Effect of ecdysterone on the differentiation of normal human keratinocytes in vitro. Eur J Dermatol 1994; 4: 558-62.
18. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res 1992; 5: 357-61.
19. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53: 1945-51.
20. Vermes I, Haanen C, Steffens-Nakken H et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
21. Noël-Hudson MS, Dusser I, Collober I et al. Human epidermis reconstructed on synthetic membrane: influence of experimental conditions on terminal differentiation in vitro. Cell Dev Biol 1995; 31: 508-15.
22. Nataraj A, Pathak S, Hopwood VL et al. bcl-2 oncogene blocks differentiation and extends viability but does not immortalize normal human keralinocytes. Int J Oncol 1994; 4: 1211-18.
23. Hale AJ, Smith CA, Sutherland LC et al. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996; 236: 1-26.
24. Carayon P, Portier M, Dussossoy D et al. Involvment of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 1996; 8: 3170-8.
25. Okun M, Korsmeyer S, Zutter M, Kupper T. Proto-oncogene bcl-2 expression in basal cell carcinoma and down regulation in psoriasis. J Invest Dermatol 1994; 102: 652 (Abstr.).
26. Bianchi L, Farrachi MG, Nini G, Piacenti M. Abnormal Bcl-2 and 'tissue' transglutaminase expression in psoriatic skin. J Invest Dermatol 1994; 103: 829-33.
27. Mitra R, Wrone-Smith T, Simonian P et al. Keratinocyte apoptosis is not strictly dependent on differentiation but is modulated by antibodies against adhesion molecules. J Invest Dermatol 1996; 106: 829 (Abstr.).
28. Jones PH, Harper S, Watt FM. Stem cell patterning and fate in human epidermis. Cell 1995; 1: 83-93.
29. Song Y, Yaar M, Gilchrest BA. Evidence that Bax mediates keratinocyte differentiation and apoptosis. J Invest Dermatol 1996; 106: 875 (Abstr.).
30. Haake AR, Graf BA, Polakowska RR. Bcl-2 down regulation is not required for keratinocyte terminal differentiation. J Invest Dermatol 1995; 104: 572 (Abstr.).
31. Pincelli C, Magnoni C, Grassili E et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high-affinity receptor: a role for Bcl-2. J Invest Dermatol 1996; 106: 829 (Abstr.).